ABSTRACT
Millions of avoidable deaths arising from the COVID-19 pandemic emphasise the need for epidemic-ready primary health care aligned with public health to identify and stop outbreaks, maintain essential services during disruptions, strengthen population resilience, and ensure health worker and patient safety. The improvement in health security from epidemic-ready primary health care is a strong argument for increased political support and can expand primary health-care capacities to improve detection, vaccination, treatment, and coordination with public health-needs that became more apparent during the pandemic. Progress towards epidemic-ready primary health care is likely to be stepwise and incremental, advancing when opportunity arises based on explicit agreement on a core set of services, improved use of external and national funds, and payment based in large part on empanelment and capitation to improve outcomes and accountability, supplemented with funding for core staffing and infrastructure and well designed incentives for health improvement. Health-care worker and broader civil society advocacy, political consensus, and bolstering government legitimacy could promote strong primary health care. Epidemic-ready primary health-care infrastructure that is able to help prevent and withstand the next pandemic will require substantial financial and structural reforms and sustained political and financial commitment. Governments, advocates, and bilateral and multilateral agencies should seize this window of opportunity before it closes.
Subject(s)
COVID-19 , Pandemics , Humans , Pandemics/prevention & control , Public Health , Primary Health CareSubject(s)
COVID-19/epidemiology , Pandemics/prevention & control , Global Health , Humans , Time FactorsABSTRACT
This Viewpoint discusses 3 areas in need of progress regarding societal approaches to pandemics and other health threats: a renaissance in public health; robustness of primary health care; and resilience of individuals and communities, with higher levels of trust in government and society.
Subject(s)
Disaster Planning , Pandemics , Public Health , Quality Improvement , Humans , COVID-19/prevention & control , Pandemics/prevention & control , Public Health/methods , Public Health/standards , SARS-CoV-2 , Quality Improvement/standards , Disaster Planning/methods , Disaster Planning/standardsSubject(s)
Pandemics , Public Health , COVID-19 , Disaster Planning , Humans , Pandemics/economics , Pandemics/prevention & control , SARS-CoV-2Subject(s)
Global Health , International Cooperation , Pandemics , Humans , Pandemics/prevention & controlSubject(s)
Health Policy , Life Expectancy , Preventive Health Services , Public Health , COVID-19 , Humans , Medical InformaticsABSTRACT
In response to the Covid-19 pandemic, many low- and middle-income countries (LMICs) expanded access to telemedicine to maintain essential health services. Although there has been attention to the accelerated growth of telemedicine in the United States and other high-income countries, the telemedicine revolution may have an even greater benefit in LMICs, where it could improve health care access for vulnerable and geographically remote patients. In this article, we survey the expansion of telemedicine for chronic disease management in LMICs and describe seven key steps needed to implement telemedicine in LMIC settings. Telemedicine can not only maintain essential medical care for chronic disease patients in LMICs throughout the Covid-19 pandemic, but also strengthen primary health care delivery and reduce socio-economic disparities in health care access over the long-term.
Subject(s)
COVID-19/therapy , Chronic Disease/therapy , Disease Management , Health Services Accessibility/organization & administration , Poverty , Telemedicine/organization & administration , Delivery of Health Care/organization & administration , Health Plan Implementation/organization & administration , Healthcare Disparities/organization & administration , Humans , Primary Health Care/organization & administration , WorkflowABSTRACT
Because severe acute respiratory coronavirus virus 2 (SARS-CoV-2) spreads easily and healthcare workers are at increased risk of both acquiring and transmitting infection, all healthcare facilities must rapidly and rigorously implement the full hierarchy of established infection controls: source control (removal or mitigation of infection sources), engineering and environmental controls, administrative controls, and personal protective equipment.
Subject(s)
COVID-19 , Health Personnel , Infection Control , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Personal Protective Equipment/supply & distribution , Risk Management/organization & administration , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/transmission , Health Facilities/standards , Health Facilities/trends , Health Facility Administration , Humans , Infection Control/methods , Infection Control/organization & administration , Occupational Health/standards , Occupational Health/trends , SARS-CoV-2ABSTRACT
It appears inevitable that severe acute respiratory syndrome coronavirus 2 will continue to spread. Although we still have limited information on the epidemiology of this virus, there have been multiple reports of superspreading events (SSEs), which are associated with both explosive growth early in an outbreak and sustained transmission in later stages. Although SSEs appear to be difficult to predict and therefore difficult to prevent, core public health actions can prevent and reduce the number and impact of SSEs. To prevent and control of SSEs, speed is essential. Prevention and mitigation of SSEs depends, first and foremost, on quickly recognizing and understanding these events, particularly within healthcare settings. Better understanding transmission dynamics associated with SSEs, identifying and mitigating high-risk settings, strict adherence to healthcare infection prevention and control measures, and timely implementation of nonpharmaceutical interventions can help prevent and control severe acute respiratory syndrome coronavirus 2, as well as future infectious disease outbreaks.